-
1
-
-
85030408768
-
-
Bethesda, MD: National Cancer Institute Available at Accessed August
-
Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review 1975-2009. Bethesda, MD: National Cancer Institute. Available at: Http://seer.cancer.gov/csr/1975-2009. Accessed August 20, 2012
-
(2012)
SEER Cancer Statistics Review 1975-2009
, vol.20
-
-
Howlader, N.1
Noone, A.M.2
Krapcho, M.3
-
3
-
-
24944557944
-
Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness
-
Borczuk AC, Kim HK, Yegen HA, Friedman RA, Powell CA. Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness. Am J Respir Crit Care Med 2005;172:729-737
-
(2005)
Am J Respir Crit Care Med
, vol.172
, pp. 729-737
-
-
Borczuk, A.C.1
Kim, H.K.2
Yegen, H.A.3
Friedman, R.A.4
Powell, C.A.5
-
4
-
-
0036580383
-
Histological typing of lung and pleural tumors
-
3rd edition, 1999): Malignant epithelial tumors
-
Shimosato Y. Histological typing of lung and pleural tumors (3rd edition, 1999): Malignant epithelial tumors. Nihon Rinsho 2002;60(Suppl 5):123-131
-
(2002)
Nihon Rinsho
, vol.60
, Issue.SUPPL. 5
, pp. 123-131
-
-
Shimosato, Y.1
-
5
-
-
33947502512
-
Lung cancer in never smokers: A review
-
Subramanian J, Govindan R. Lung cancer in never smokers: A review. J Clin Oncol 2007;25:561-570
-
(2007)
J Clin Oncol
, vol.25
, pp. 561-570
-
-
Subramanian, J.1
Govindan, R.2
-
6
-
-
34648815009
-
Lung cancer in never smokers-A different disease
-
Sun F, Schiller J, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007;7:778-790
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 778-790
-
-
Sun, F.1
Schiller, J.2
Gazdar, A.F.3
-
7
-
-
79961108629
-
Reduced lung-cancer mortality with low-dose computed tomographic screening
-
National Lung Screening Trial Research Team
-
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. NEJM 2011;365:395-409
-
(2011)
NEJM
, Issue.365
, pp. 395-409
-
-
Aberle, D.R.1
Adams, A.M.2
-
8
-
-
42549089715
-
Lung adenocarcinoma: Guiding EGFR-targetedtherapy and beyond
-
Ladanyi M, Pao W. Lung adenocarcinoma: Guiding EGFR-targetedtherapy and beyond. Mod Pathol 2008;21:16-22
-
(2008)
Mod Pathol
, vol.21
, pp. 16-22
-
-
Ladanyi, M.1
Pao, W.2
-
9
-
-
54549094903
-
Somatic mutations affect key pathways in lung adenocarcinoma
-
Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-1075
-
(2008)
Nature
, vol.455
, pp. 1069-1075
-
-
Ding, L.1
Getz, G.2
Wheeler, D.A.3
-
10
-
-
64249109679
-
EGFR and KRAS mutations in patients with adenocarcinoma of the lung
-
Jang TW, Oak CH, Chang HK, Suo SJ, Jung MH. EGFR and KRAS mutations in patients with adenocarcinoma of the lung. Korean J Intern Med 2009;24:48-54
-
(2009)
Korean J Intern Med
, vol.24
, pp. 48-54
-
-
Jang, T.W.1
Oak, C.H.2
Chang, H.K.3
Suo, S.J.4
Jung, M.H.5
-
11
-
-
0036645286
-
Inactivation of STK11/ STK11 is a common event in adenocarcinoma of the lung
-
Sanchez-Cespedes M, Parrella P, Esteller M, et al. Inactivation of STK11/ STK11 is a common event in adenocarcinoma of the lung. Cancer Res 2002;62:3659-3662
-
(2002)
Cancer Res
, vol.62
, pp. 3659-3662
-
-
Sanchez-Cespedes, M.1
Parrella, P.2
Esteller, M.3
-
12
-
-
52449105508
-
Association of p16 homozygous deletions with clinicopathologic characteristics and EGFR/KRAS/p53 mutations in lung adenocarcinoma
-
Iwakawa R, Kohno T, Anami Y, et al. Association of p16 homozygous deletions with clinicopathologic characteristics and EGFR/KRAS/p53 mutations in lung adenocarcinoma. Clin Cancer Res 2008;14:3746-3753
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3746-3753
-
-
Iwakawa, R.1
Kohno, T.2
Anami, Y.3
-
13
-
-
0033592584
-
Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
-
Sanchez-Cespedes M, Reed AL, Buta M, et al. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene 1999;18:5843-5849
-
(1999)
Oncogene
, vol.18
, pp. 5843-5849
-
-
Sanchez-Cespedes, M.1
Reed, A.L.2
Buta, M.3
-
14
-
-
0033626213
-
Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53
-
Seike M, Gemma A, Hosoya Y, et al. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Clin Cancer Res 2000;6:4307-4313
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4307-4313
-
-
Seike, M.1
Gemma, A.2
Hosoya, Y.3
-
15
-
-
84866894408
-
The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers
-
The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012;489:519-525
-
(2012)
Nature
, Issue.489
, pp. 519-525
-
-
-
16
-
-
84866410479
-
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
-
Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012;150:1107-1120
-
(2012)
Cell
, Issue.150
, pp. 1107-1120
-
-
Imielinski, M.1
Berger, A.H.2
Hammerman, P.S.3
-
17
-
-
33747587608
-
Regulation of the INK4b-ARF-INK4a tumour suppressor locus: All for one or one for all
-
Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: All for one or one for all. Nat Rev Mol Cell Biol 2006;7:667-677
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, pp. 667-677
-
-
Gil, J.1
Peters, G.2
-
18
-
-
7044231343
-
The p16INK4a-RB pathway: Molecular link between cellular senescence and tumor suppression
-
Ohtani N, Yamakoshi K, Takahashi A, Hara E. The p16INK4a-RB pathway: Molecular link between cellular senescence and tumor suppression. J Med Invest 2004;51:146-153
-
(2004)
J Med Invest
, vol.51
, pp. 146-153
-
-
Ohtani, N.1
Yamakoshi, K.2
Takahashi, A.3
Hara, E.4
-
19
-
-
33644502525
-
Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer
-
Kraunz KS, Nelson HH, Lemos M, Godleski JJ, Wiencke JK, Kelsey KT. Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer. Int J Cancer 2006;118:1364-1369
-
(2006)
Int J Cancer
, vol.118
, pp. 1364-1369
-
-
Kraunz, K.S.1
Nelson, H.H.2
Lemos, M.3
Godleski, J.J.4
Wiencke, J.K.5
Kelsey, K.T.6
-
20
-
-
2442462112
-
Dose effect of smoking on aberrant methylation in non-small cell lung cancers
-
Toyooka S, Suzuki M, Tsuda T, et al. Dose effect of smoking on aberrant methylation in non-small cell lung cancers. Int J Cancer 2004;110:462-464
-
(2004)
Int J Cancer
, vol.110
, pp. 462-464
-
-
Toyooka, S.1
Suzuki, M.2
Tsuda, T.3
-
21
-
-
0035870282
-
P16(INK4a) and histologyspecific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer
-
Kim DH, Nelson HH, Wiencke JK, et al. p16(INK4a) and histologyspecific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001;61:3419-3424
-
(2001)
Cancer Res
, vol.61
, pp. 3419-3424
-
-
Kim, D.H.1
Nelson, H.H.2
Wiencke, J.K.3
-
23
-
-
48249114422
-
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
-
Koivunen JP, Mermel C, Zejnullahu K, et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 2008;14:4275-4283
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4275-4283
-
-
Koivunen, J.P.1
Mermel, C.2
Zejnullahu, K.3
-
24
-
-
84887212361
-
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines
-
Gandhi J, Zhang J, Xie Y, et al. Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One 2009;4:e4576
-
(2009)
PLoS One
, vol.4
-
-
Gandhi, J.1
Zhang, J.2
Xie, Y.3
-
25
-
-
33845662751
-
Application of a methylation gene panel by quantitative PCR for lung cancers
-
Shivapurkar N, Stastny V, Suzuki M, et al. Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett 2007;247:56-71
-
(2007)
Cancer Lett
, vol.247
, pp. 56-71
-
-
Shivapurkar, N.1
Stastny, V.2
Suzuki, M.3
-
26
-
-
34548700125
-
Innovative proteomic approaches for cancer biomarker discovery
-
Faca V, Krasnoselsky A, Hanash S. Innovative proteomic approaches for cancer biomarker discovery. Biotechniques 2007;43:279, 281-273, 285
-
(2007)
Biotechniques
, vol.43
, Issue.279
, pp. 281-285
-
-
Faca, V.1
Krasnoselsky, A.2
Hanash, S.3
-
27
-
-
70449433271
-
Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells
-
Soh J, Okumura N, Lockwood WW, et al. Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One 2009;4:e7464
-
(2009)
PLoS One
, vol.4
-
-
Soh, J.1
Okumura, N.2
Lockwood, W.W.3
-
28
-
-
28844501639
-
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
-
Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006;118:257-262
-
(2006)
Int J Cancer
, vol.118
, pp. 257-262
-
-
Shigematsu, H.1
Gazdar, A.F.2
-
29
-
-
20044364940
-
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
-
Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-346
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 339-346
-
-
Shigematsu, H.1
Lin, L.2
Takahashi, T.3
-
31
-
-
58249098396
-
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors
-
Vaissire T, Hung RJ, Zaridze D, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009;69:243-252
-
(2009)
Cancer Res
, vol.69
, pp. 243-252
-
-
Vaissire, T.1
Hung, R.J.2
Zaridze, D.3
-
32
-
-
0002100348
-
Primary, secondary, and meta-analysis of research
-
Glass GV. Primary, secondary, and meta-analysis of research. Educat Res 1976;5:3-8
-
(1976)
Educat Res
, vol.5
, pp. 3-8
-
-
Glass, G.V.1
-
34
-
-
0035132145
-
Aberrant promoter methylation of multiple genes in non-small cell lung cancers
-
Zöchbauer-Müller S, Fong KM, Virmani AK, et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001;61(1):249-255
-
(2001)
Cancer Res
, vol.61
, Issue.1
, pp. 249-255
-
-
Zöchbauer-Müller, S.1
Fong, K.M.2
Virmani, A.K.3
-
35
-
-
0037427808
-
Smoke exposure, histologic type and geography-related differences in the methylation profiles of nonsmall cell lung cancer
-
Toyooka S, Maruyama R, Toyooka KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of nonsmall cell lung cancer. Int J Cancer 2003;103:153-160
-
(2003)
Int J Cancer
, vol.103
, pp. 153-160
-
-
Toyooka, S.1
Maruyama, R.2
Toyooka, K.O.3
-
36
-
-
0042563143
-
Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers
-
Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 2003;94:589-592
-
(2003)
Cancer Sci
, vol.94
, pp. 589-592
-
-
Yanagawa, N.1
Tamura, G.2
Oizumi, H.3
Takahashi, N.4
Shimazaki, Y.5
Motoyama, T.6
-
37
-
-
79956115427
-
Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: Relation with smoking status
-
Yanagawa N, Tamura G, Oizumi H, Endoh M, Sadahiro M, Motoyama T. Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: Relation with smoking status. Anticancer Res 2011;31:1211-1214
-
(2011)
Anticancer Res
, Issue.31
, pp. 1211-1214
-
-
Yanagawa, N.1
Tamura, G.2
Oizumi, H.3
Endoh, M.4
Sadahiro, M.5
Motoyama, T.6
-
38
-
-
4344672497
-
Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma
-
Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Pathol Int 2004;54:549-555
-
(2004)
Pathol Int
, vol.54
, pp. 549-555
-
-
Furonaka, O.1
Takeshima, Y.2
Awaya, H.3
Ishida, H.4
Kohno, N.5
Inai, K.6
-
39
-
-
33646427172
-
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients
-
Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P. Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia 2006;8:46-51
-
(2006)
Neoplasia
, vol.8
, pp. 46-51
-
-
Liu, Y.1
Lan, Q.2
Siegfried, J.M.3
Luketich, J.D.4
Keohavong, P.5
-
40
-
-
35148859298
-
Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: Correlation with smoking
-
Georgiou E, Valeri R, Tzimagiorgis G, et al. Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: Correlation with smoking. Eur J Cancer Prev 2007;16:396-402
-
(2007)
Eur J Cancer Prev
, vol.16
, pp. 396-402
-
-
Georgiou, E.1
Valeri, R.2
Tzimagiorgis, G.3
-
41
-
-
0041837642
-
Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer
-
Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Int J Cancer 2003;106:913-918
-
(2003)
Int J Cancer
, vol.106
, pp. 913-918
-
-
Jarmalaite, S.1
Kannio, A.2
Anttila, S.3
Lazutka, J.R.4
Husgafvel-Pursiainen, K.5
-
42
-
-
58149357596
-
Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer
-
Suga Y, Miyajima K, Oikawa T, et al. Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer. Oncol Rep 2008;20:1137-1142
-
(2008)
Oncol Rep
, vol.20
, pp. 1137-1142
-
-
Suga, Y.1
Miyajima, K.2
Oikawa, T.3
-
43
-
-
36148990637
-
Hypermethylation of p16 in Korean non-small cell lung cancer patients
-
Hong YS, Kim NY, Kim HK, et al. Hypermethylation of p16 in Korean non-small cell lung cancer patients. J Korean Med Sci 2007;22:S32-S37
-
(2007)
J Korean Med Sci
, vol.22
-
-
Hong, Y.S.1
Kim, N.Y.2
Kim, H.K.3
-
44
-
-
20044383744
-
Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers
-
Divine KK, Pulling LC, Marron-Terada PG, et al. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Int J Cancer 2005;114:400-405
-
(2005)
Int J Cancer
, vol.114
, pp. 400-405
-
-
Divine, K.K.1
Pulling, L.C.2
Marron-Terada, P.G.3
-
45
-
-
11144304060
-
Frequent p16INK4a promoter hypermethylation in human papillomavirus- infected female lung cancer in Taiwan
-
Wu MF, Cheng YW, Lai JC, et al. Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int J Cancer 2005;113:440-445
-
(2005)
Int J Cancer
, vol.113
, pp. 440-445
-
-
Wu, M.F.1
Cheng, Y.W.2
Lai, J.C.3
-
46
-
-
34548510399
-
Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population
-
Kim DS, Cha SI, Lee JH, et al. Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population. Lung Cancer 2007;58:1-6
-
(2007)
Lung Cancer
, vol.58
, pp. 1-6
-
-
Kim, D.S.1
Cha, S.I.2
Lee, J.H.3
-
47
-
-
67650164499
-
Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers
-
Tessema M, Yu YY, Stidley CA, et al. Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers. Carcinogenesis 2009;30:1132-1138
-
(2009)
Carcinogenesis
, vol.30
, pp. 1132-1138
-
-
Tessema, M.1
Yu, Y.Y.2
Stidley, C.A.3
-
48
-
-
8444253477
-
Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung
-
Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 2004;25:2165-2171
-
(2004)
Carcinogenesis
, vol.25
, pp. 2165-2171
-
-
Kim, J.S.1
Kim, H.2
Shim, Y.M.3
Han, J.4
Park, J.5
Kim, D.H.6
-
49
-
-
32944468706
-
Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers
-
Toyooka S, Tokumo M, Shigematsu H, et al. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 2006;66:1371-1375
-
(2006)
Cancer Res
, vol.66
, pp. 1371-1375
-
-
Toyooka, S.1
Tokumo, M.2
Shigematsu, H.3
-
50
-
-
34547926839
-
STK11 modulates lung cancer differentiation and metastasis
-
Ji H, Ramsey M, Hayes DN, et al. STK11 modulates lung cancer differentiation and metastasis. Nature 2007;448:807-811
-
(2007)
Nature
, vol.448
, pp. 807-811
-
-
Ji, H.1
Ramsey, M.2
Hayes, D.N.3
-
51
-
-
83255181725
-
Cigarette smoking and p16INK4? Gene promoter hypermethylation in non-small cell lung carcinoma patients: A meta-analysis
-
Zhang B, Zhu W, Yang P, et al. Cigarette smoking and p16INK4? gene promoter hypermethylation in non-small cell lung carcinoma patients: A meta-analysis. PLoS One 2011;6:e28882
-
(2011)
PLoS One
, Issue.6
-
-
Zhang, B.1
Zhu, W.2
Yang, P.3
|